Results 31 to 40 of about 2,032 (166)

Inhibition of serotonin-amplified human platelet aggregation by ketanserin, ritanserin, and the ergoline 5HT2 receptor antagonists - LY53857, sergolexole, and LY237733

, 1990
Paul McBride, J. John Mann, Esther A. Nimchinsky, Marlene L. Cohen   +3 more
openalex   +1 more source

Effects of the 5-HT_2A receptor antagonist volinanserin on head-twitch response and intracranial self-stimulation depression induced by different structural classes of psychedelics in rodents. [PDF]

Psychopharmacology (Berl), 2022
Jaster AM, Elder H, Marsh SA, de la Fuente Revenga M, Negus SS, González-Maeso J.   +5 more
europepmc   +1 more source

Cover Picture: Ergoline‐Derived Inverse Agonists of the Human H3 Receptor for the Treatment of Narcolepsy (ChemMedChem 8/2014) [PDF]

, 2014
Yves P. Auberson, Thomas Troxler, Xuechun Zhang, Charles R. Yang, Markus Fendt, Dominik Feuerbach, Yu‐Chih Liu, Bharat Lagu, Andreas Lerchner, Mark H. Perrone, Lijun Lei, Chao Zhang, Chunxiu Wang, Tielin Wang, Mark G. Bock   +14 more
openalex   +1 more source

Synthetic Studies toward (+)-Lysergic Acid: Construction of the Tetracyclic Ergoline Skeleton

, 2009
Tohru Fukuyama, Tohru Inoue, Satoshi Yokoshima   +2 more
openalex   +1 more source

The structural diversity of psychedelic drug actions revealed. [PDF]

Nat Commun
Gumpper RH, Jain MK, Kim K, Sun R, Sun N, Xu Z, DiBerto JF, Krumm BE, Kapolka NJ, Kaniskan HÜ, Nichols DE, Jin J, Fay JF, Roth BL.   +13 more
europepmc   +1 more source

Rare causes of anisocoria: Ipratropium bromide and Angel's trumpet. [PDF]

North Clin Istanb, 2021
Ekici A, Caglar B, Kara O, Oto A, Kilic N.   +4 more
europepmc   +1 more source

Natural Product-Inspired Dopamine Receptor Ligands. [PDF]

J Med Chem
Dorogan M, Namballa HK, Harding WW.
europepmc   +1 more source

The D₁receptor‐mediated effects of the ergoline derivative LEK‐8829 in rats with unilateral 6‐hydroxydopamine lesions [PDF]

, 1996
Marko Živin, Lilijana Šprah, Dušan Sket   +2 more
openalex   +1 more source

μ-opioid receptor agonists and psychedelics: pharmacological opportunities and challenges. [PDF]

Front Pharmacol, 2023
Salinsky LM, Merritt CR, Zamora JC, Giacomini JL, Anastasio NC, Cunningham KA.   +5 more
europepmc   +1 more source

Ethical Considerations Regarding Psychedelics for Clinical Pain Research. [PDF]

J Pain Res
Robinson CL, Slitzky M, Schatman ME, Yong RJ, Lehman AD, Kaynar AM, Shivanekar SP, Emerick T.   +7 more
europepmc   +1 more source